Interleukin (IL)-12, IL-2, interferon-γ gene polymorphisms in subacute sclerosing panencephalitis patients

References

• Atabani S F, Byrnes A A, Jaye A, Kidd I M, Magnusen A F, Whittle H, Karp C L. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001; 184: 1–9
   PubMedGoogle Scholar
• Ayata M, Hayashi K, Seto T, Murata R, Ogura H. The matrix gene expression of subacute sclerosing panencephalitis (SSPE) virus (Osaka-1 strain): a comparison of two sibling viruses isolated from different lobes of an SSPE brain. Microbiol Immunol 1998; 42: 773–780
   Google Scholar
• Baczko K, Lampe J, Liebert U G, Brinckmann U, ter Meulen V, Pardowitz I, Budka H, Cosby S L, Isserte S, Rima B K. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993; 197: 188–195
   PubMedGoogle Scholar
• Bellini W J, Rota J S, Lowe L E, Katz R S, Dyken P R, Zaki S R, Shieh W J, Rota P A. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 2005; 192: 1686–1693
   PubMedGoogle Scholar
• Brajczewska-Fischer W, Iwinska B, Kruszewska J, Korlak J, Czlonkowska A. Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerbation of multiple sclerosis. Acta Neurol Scand 1989; 80: 390–393
   Google Scholar
• Breschkin A M, Morgan E M, McKimm J, Rapp F. SSPE-BIKEN: a naturally arising hemagglutination-defective mutant of measles virus. J Med Virol 1979; 4: 67–80
   Google Scholar
• Dhib-Jalbut S, Jacobson S, McFarlin D E, McFarland H F. Impaired measles-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann N Y Acad Sci 1988; 540: 645–648
   Google Scholar
• Dyken P R. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 2001; 7: 217–225
   Google Scholar
• Gascon G G. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996; 3: 260–269
   PubMedGoogle Scholar
• Graves M. Subacute sclerosing panencephalitis. Neurol Clin 1984; 2: 267–280
   PubMed Web of Science ®Google Scholar
• Hall M A, McGlinn E, Coakley G, Fisher S A, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran T P, Jr., Ollier W E, Panayi G S, Lanchbury J S. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000; 1: 219–224
   PubMed Web of Science ®Google Scholar
• Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good R A, Takeshita K. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J NeuroVirol 2000; 6: 121–126
   PubMed Web of Science ®Google Scholar
• Huang D, Cancilla M R, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000; 1: 515–520
   PubMed Web of Science ®Google Scholar
• Ichiyama T, Siba P, Suarkia D, Reeder J, Takasu T, Miki K, Maeba S, Furukawa S. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Cytokine 2006; 33: 17–20
   PubMedGoogle Scholar
• Inoue T, Kira R, Nakao F, Ihara K, Bassuny W M, Kusuhara K, Nihei K, Takeshita K, Hara T. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002; 59: 822–827
   PubMedGoogle Scholar
• Karp C L. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 1999; 168: 91–101
   Google Scholar
• Karp C L, Wysocka M, Wahl L M, Ahearn J M, Cuomo P J, Sherry B, Trinchieri G, Griffin D E. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273: 228–231
   PubMed Web of Science ®Google Scholar
• Ma X, Reich R A, Gonzalez O, Pan X, Fothergill A K, Starke J R, Teeter L D, Musser J M, Graviss E A. No evidence for association between the polymorphism in the 3′ untranslated region of interleukin-12B and human susceptibility to tuberculosis. J Infect Dis 2003; 188: 1116–1118
   Google Scholar
• Matesanz F, Fedetz M, Leyva L, Delgado C, Fernandez O, Alcina A. Effects of the multiple sclerosis associated −330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol 2004; 148: 212–217
   PubMed Web of Science ®Google Scholar
• Mytilineos J. Cytokine polymorphisms HLA 2007: Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Congress, J A Hansen. IHWG Press, Seattle, WA 2007
   Google Scholar
• Nagano I, Nakamura S, Yoshioka M, Kogure K. Immunocytochemical analysis of the cellular infiltrate in brain lesions in subacute sclerosing panencephalitis. Neurology 1991; 41: 1639–1642
   Google Scholar
• Nagano I, Nakamura S, Yoshioka M, Onodera J, Kogure K, Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994; 44: 710–715
   Google Scholar
• Onal A E, Gurses C, Direskeneli G S, Yilmaz G, Demirbilek V, Yentur S P, Ozel S, Yapici Z, Tumerdem Y, Gokyigit A. Subacute sclerosing panencephalitis surveillance study in Istanbul. Brain Dev 2006; 28: 183–189
   PubMed Web of Science ®Google Scholar
• Ozturk A, Gurses C, Baykan B, Gokyigit A, Eraksoy M. Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol 2002; 17: 25–29
   PubMedGoogle Scholar
• Saruhan-Direskeneli G, Bicakcigil M, Yilmaz V, Kamali S, Aksu K, Fresko I, Akkoc N, Kiraz S, Ozer H TE, Tunc E, Yucel E, Karaarslan Y, Uyar F A, Doganavsargil E, Inanc M, Direskeneli H. Interleukin (IL)-12, IL-2, and IL-6 Gene Polymorphisms in Takayasu's Arteritis from Turkey. Human Immunol 2006; 67: 735–740
   PubMed Web of Science ®Google Scholar
• Saruhan-Direskeneli G, Gurses C, Demirbilek V, Yentur S P, Yilmaz G, Onal E, Yapici Z, Yalcinkaya C, Cokar O, Akman-Demir G, Gokyigit A. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis. Cytokine 2005; 32: 104–110
   Google Scholar
• Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S. Measles virus interactions with cellular receptors: consequences for viral pathogenesis. J NeuroVirol 2001; 7: 391–9
   PubMed Web of Science ®Google Scholar
• Schneider-Schaulies J, ter Meulen V, Schneider-Schaulies S. Measles infection of the central nervous system. J NeuroVirol 2003; 9: 247–252
   Google Scholar
• Schnorr J-J, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A 1997; 94: 5326–5331
   PubMed Web of Science ®Google Scholar
• Seegers D, Zwiers A, Strober W, Pena A S, Bouma G. A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419–423
   PubMed Web of Science ®Google Scholar
• Tekgul H, Tutuncuoglu S, Kutukculer N, Dizdarer G, Huseyinov A. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. J Child Neurol 1999; 14: 418–421
   PubMedGoogle Scholar
• Torisu H, Kusuhara K, Kira R, Bassuny W M, Sakai Y, Sanefuji M, Takemoto M, Hara T. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 2004; 62: 457–460
   PubMed Web of Science ®Google Scholar
• Tso H, Lau Y L, Tam C M, Wong H S, Chiang A K. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 2004; 190: 913–919
   Google Scholar
• van Els C, Nanan R. T cell responses in acute measles. Viral Immunol 2002; 15: 435–450
   Google Scholar
• Yentur S P, Gurses C, Demirbilek V, Yilmaz G, Onal A E, Yapici Z, Yalcinkaya C, Cokar O, Gokyigit A, Saruhan-Direskeneli G. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 2005; 170: 179–185
   Google Scholar
• Yilmaz V, Yentur S P, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30: 188–194
   Google Scholar